Doxorubicin Hydrochloride Liposome
These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for Doxorubicin hydrochloride liposome injection. Doxorubicin Hydrochloride Liposome Injection, for intravenous useInitial U.S. Approval: 1995
cf25a018-e795-49e4-8533-a581f8366dd9
HUMAN PRESCRIPTION DRUG LABEL
May 31, 2022
Baxter Healthcare Company
DUNS: 005083209
Baxter Healthcare Corporation
DUNS: 005083209
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Doxorubicin Hydrochloride Liposome
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
Doxorubicin Hydrochloride Liposome
Product Details
FDA regulatory identification and product classification information